Skip to main content
  • AETC National Coordinating Resource Center
  • Resources for Clinicians
  • AETC Directory
  • Download App
Home

Breadcrumb

  1. Home
  2. Antiretrovirals

Nonnucleoside reverse transcriptase inhibitors

U.S. Guidelines Links
Characteristics of Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
Other Reference Links
National HIV Curriculum
Abbreviation(s)
NNRTI
ARVs
Doravirine
Efavirenz
Etravirine
Nevirapine
Rilpivirine
Subscribe to Nonnucleoside reverse transcriptase inhibitors
Related Co-medications
Doravirine
Efavirenz
Etravirine
Nevirapine
Rilpivirine
Rilpivirine (IM)
  • About
  • Contact Us
  • Log in

Apple Store

   Google Play

This project is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of an award (grant number U1OHA28686) totaling $1,700,000 with 0% financed with non-governmental sources. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by HRSA, HHS, or the U.S. Government.